Additional GWAS and meta-analyses provide further evidence supporting these findings, suggesting that BCL9 is implicated in the negative symptoms of schizophrenia and designating it as one of the most prominent high-risk candidate genes for the disorder. The gene discussed is BCL9; the disease is schizophrenia.